Vyas Cancer Research Private Limited, a active private limited company, was established on 07 October 2015 in Visakhapatnam, Andhra Pradesh, India. Engaging in oncology clinics & cancer treatment within the hospital and medical care sector, it holds CIN: U85191AP2015PTC097487. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹20.72 Cr and a paid-up capital of ₹12.01 Cr.
It upholds a compliant status. Its leadership includes Hima Bindu Gaddipati (Managing Director), Mandar Vivekanand Kulkarni (Director), Sambasivarao Gaddipati (Director). Past directors included Hima Bindu Gaddipati, Rafeeq Mohammed, Mandar Vivekanand Kulkarni. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Anchorage,Plotno.9&12,Tp.No.9/74,Surveyno.119,Blockno.4,Maharanipeta,, Visakhapatnam, Andhra Pradesh, 530002.
U85191AP2015PTC097487
097487
07 October 2015
₹20.72 Cr
₹12.01 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Vyas Cancer Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hima Bindu Gaddipati | Managing Director | 07 Oct 2015 | Current |
| Mandar Vivekanand Kulkarni | Director | 02 Feb 2019 | Current |
| Sambasivarao Gaddipati | Director | 07 Oct 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Oct 2024 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 29 Aug 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vyas Cancer Research Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 182.02% increase. The company also saw a slight decrease in profitability, with a 1.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.86%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Vyas Cancer Research had a promoter holding of 84.15% and a public holding of 15.85%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Vyas Cancer Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Vyas Cancer Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vyas Cancer Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rani Rai was appointed as a Company Secretary was appointed as a Company Secretary on 02 Dec 2023 & has been associated with this company since 1 year 11 months . was recorded as a recent event.
The activity Vyas Cancer Research Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was completed.
Progress on Vyas Cancer Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Vijayawada. was documented.
Progress on Mandar Vivekanand Kulkarni was appointed as a Director was appointed as a Director on 02 Feb 2019 & has been associated with this company since 6 years 9 months . was documented.
The activity Hima Bindu Gaddipati was appointed as a Managing Director was appointed as a Managing Director on 07 Oct 2015 & has been associated with this company since 10 years 1 month . was completed.
The activity Sambasivarao Gaddipati was appointed as a Director was appointed as a Director on 07 Oct 2015 & has been associated with this company since 10 years 1 month . was completed.
The CIN of Vyas Cancer Research Private Limited is U85191AP2015PTC097487.
Vyas Cancer Research Private Limited is headquartered at Anchorage,Plotno.9&12,Tp.No.9/74,Surveyno.119,Blockno.4,Maharanipeta,, Visakhapatnam, Andhra Pradesh, 530002.
Vyas Cancer Research Private Limited was incorporated on 07 October 2015.
The current directors of Vyas Cancer Research Private Limited are
The primary industry of Vyas Cancer Research Private Limited is Hospital And Medical Care.
Vyas Cancer Research Private Limited is unlisted.
The authorized capital of Vyas Cancer Research Private Limited is ₹20.72 Cr, and the paid-up capital is ₹12.01 Cr.
The compliance status of Vyas Cancer Research Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX